Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute... by Shannon Cope, Dieter Ayers, Jie Zhang, Katharine Batt, Jeroen P. Jansen

Subjects: Get full text

Infections in hematologic malignancy patients treated by CD19 chimeric antigen receptor T‐cell therapy by Linghui Zhou, Elaine Tan Su Yin, Houli Zhao, Shuyi Ding, Yongxian Hu, He Huang

Subjects: Get full text

Severe anaphylaxis after chimeric antigen receptor T‐cell injection: a case report by Sarah Morin, Filippo Boroli, Sophie Vandenberghe‐Durr, Daniele Allali, Stavroula Masouridi‐Levrat, Yves Chalandon, Federico Simonetta

Subjects: Get full text

The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL by Forsberg MH, Das A, Saha K, Capitini CM

Subjects: Get full text

Monitoring CAR T cells in peripheral blood by flow cytometry following Tisagenlecleucel in Fundeni Clinical Institute, Bucharest by Popa Delia C., Sandu Horia M., Suciu Raluca, Ţica Valeria G., Şerbănică Andreea, Şerbănică Ionut, Jercan Cristina, Coriu Daniel, Tanase Alina, Coliţă Anca

Subjects: Get full text

CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia by Vairy S, Lopes Garcia J, Teira P, Bittencourt H

Subjects: Get full text

Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel by Reyes Maria Martín‐Rojas, Ignacio Gómez‐Centurión, Rebeca Bailén, Mariana Bastos, Francisco Diaz‐Crespo, Diego Carbonell, Rafael Correa‐Rocha, Marjorie Pion, Cristina Muñoz, Milagros Sancho, Isabel Gómez Fernández, Gillen Oarbeascoa, Ana Pérez‐Corral, Carolina Martínez‐Laperche, Javier Anguita, Ismael Buño, Javier Menárguez, Jose Luis Díez‐Martín, Mi Kwon

Subjects: Get full text

Case report: Tisagenlecleucel for treatment of relapsed B- acute lymphoblastic leukemia in a patient with CHEK2 mutation by Abraham Ipe, Anne Angiolillo, Anne Angiolillo, David Jacobsohn, David Jacobsohn, Jinjun Cheng, Jinjun Cheng, Miriam Bornhorst, Miriam Bornhorst, Joyce Turner, Joyce Turner, Anant Vatsayan, Anant Vatsayan

Subjects: Get full text

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance by Michael M. Boyiadzis, Madhav V. Dhodapkar, Renier J. Brentjens, James N. Kochenderfer, Sattva S. Neelapu, Marcela V. Maus, David L. Porter, David G. Maloney, Stephan A. Grupp, Crystal L. Mackall, Carl H. June, Michael R. Bishop

Subjects: Get full text

Characterization of the input material quality for the production of tisagenlecleucel by multiparameter flow cytometry and its relation to the clinical outcome by Martin Štach, Martin Štach, Robert Pytlík, Robert Pytlík, Kristýna Šmilauerová, Kristýna Šmilauerová, Jana Rychlá, Martin Mucha, Martin Mucha, Jan Musil, Abhishek Koladiya, Matěj Nemec, Martina Petráčková, Iva Kaštánková, Pavla Pecherková, Lucie Šrámková, Kamila Polgárová, Kamila Polgárová, Marek Trněný, Marek Trněný, Petr Lesný, Jan Vydra, Pavel Otáhal, Pavel Otáhal

Subjects: Get full text

The treatment of follicular lymphoma with CD19-directed chimeric antigen receptor T-cell therapy by Ryan Jacobs, Caron Jacobson

Subjects: Get full text

Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world pattern... by Valentin Barsan, Yimei Li, Snehit Prabhu, Christina Baggott, Khanh Nguyen, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather Stefanski, Julie-An Talano, Amy Moskop, Susanne Baumeister, Michael R. Verneris, Gary Douglas Myers, Nicole A. Karras, Stacy Cooper, Muna Qayed, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy Keating, Vanessa Fabrizio, Vasant Chinnabhandar, Michael Kunicki, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz

Subjects: Get full text

Efficacy and Safety of Axicabtagene Ciloleucel and Tisagenlecleucel Administration in Lymphoma Patients With Secondary CNS Involvement: A Systematic Review by XiaoQin Wu, XinYue Zhang, RenDe Xun, MengSi Liu, Zhen Sun, JianChao Huang

Subjects: Get full text

CARs on a highway with roadblocks by Lorenzo Galluzzi, Peter Martin

Subjects: Get full text

Current and Future Perspectives for Chimeric Antigen Receptor T Cells Development in Poland by Tomasz J. Ślebioda, Marcin Stanisławowski, Lucyna Kaszubowska, Jan M. Zaucha, Michał A. Żmijewski

Subjects: Get full text

Cardiovascular toxicity of tisagenlecleucel in children and adolescents: analysis of spontaneous reports submitted to FAERS by Ganggang Wang, Lin Su, Yanjun Liu, Xiaohan Yang, Yi Li, Qi Mei, Qi Mei, Wen Gao

Subjects: “…tisagenlecleucel…”
Get full text

First pediatric B-acute lymphoblastic leukemia patient treated with anti-CD19 chimeric antigen receptor T-cell therapy: Long-term remission or early cure? by Dimitrios Bouzianas, Stella Bouziana

Subjects: Get full text

Cost-Effectiveness and Budget Impact Analyses of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia from the Sin... by Wang XJ, Wang YH, Ong MJC, Gkitzia C, Soh SY, Hwang WYK

Subjects: “…tisagenlecleucel…”
Get full text

Optimizing the commercial manufacturing of tisagenlecleucel for patients in Japan: A 4-year experiential journey by Fumiko Iwamoto, David Fong, Margarida Rodrigues, Yoshie Tsurumaki

Subjects: Get full text

Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lis... by Guillaume Cartron, Christopher P. Fox, Fei Fei Liu, Ana Kostic, Jens Hasskarl, Daniel Li, Ashley Bonner, Yixie Zhang, David G. Maloney, John Kuruvilla

Subjects: Get full text